Bachem Holding AG (LON:0QND)

Market Cap	4.33B
Revenue (ttm)	622.20M
Net Income (ttm)	123.16M
Shares Out	n/a
EPS (ttm)	1.65
PE Ratio	35.19
Forward PE	32.28
Dividend	0.78 (1.25%)
Ex-Dividend Date	May 5, 2025

Volume	6,027
Average Volume	10,425
Open	62.85
Previous Close	62.21
Day's Range	61.35 - 62.85
52-Week Range	43.98 - 78.80
Beta	0.83
RSI	38.80
Earnings Date	Mar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,207
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial numbers in CHF